Evidence map›Paper›PMID 41457095›Full record

ArticleNature communications2025

Viral entry shapes HCMV latency establishment.

Yaarit Kitsberg, Aharon Nachshon, Tamar Arazi, Karin Broennimann, Tal Fisher, Alexander Wainstein, Yaara Finkel, Noam Stern-Ginossar, Michal Schwartz

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yaarit KitsbergDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-1446-0089
Aharon NachshonDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-2283-5220
Tamar AraziDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Karin BroennimannDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Tal FisherDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Alexander WainsteinDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Yaara FinkelDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-3843-2357
Noam Stern-GinossarDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. noam.stern-ginossar@weizmann.ac.il.ORCID http://orcid.org/0000-0003-3583-5932
Michal SchwartzDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. michalsc@weizmann.ac.il.ORCID http://orcid.org/0000-0001-5442-0201

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) CoG-2019-864012
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) infection results in either productive or latent infection, the latter enabling life-long viral persistence. Monocytes support latent infection but become permissive to productive infection upon differentiation into macrophages. These differentiation-driven differences have been largely attributed to chromatin-mediated repression of the viral genome. Using metabolic labeling of newly synthesized RNA, we observe markedly lower viral transcription at early stages of infection in monocytes compared to macrophages. Unbiased comparison reveals that this difference is partly explained by inefficient viral entry in monocytes: fewer viruses enter, and correspondingly, fewer genomes reach the nucleus. Indeed, ectopic expression of known HCMV entry receptors in monocytes enhances viral entry and enables productive infection, demonstrating that these cells can support full lytic replication if entry is efficient. We further identify integrin β3 as a differentiation-induced surface protein playing an important role in HCMV entry into macrophages, partially accounting for the observed differences in entry efficiency. Finally, we show that cells receiving fewer viral genomes are the ones that establish latent infection and have the capacity to reactivate. Overall, our findings reveal that entry is a previously unrecognized factor contributing to latent infection in monocytes, adding a critical layer to the paradigm of HCMV latency.

Indexed as

CytomegalovirusCytomegalovirus InfectionsVirus InternalizationVirus LatencyCell DifferentiationGenome, ViralHumansIntegrin beta3MacrophagesMonocytesVirus ReplicationIntegrin beta3

Identifiers

PMID41457095
PMCPMC12868673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.